BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 30816620)

  • 1. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
    Martín-Sánchez E; Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Blanco-Luquin I; Córdoba A; Vicente-García F; Pérez-Janices N; Escors D; Megías D; López-Serra P; Esteller M; Illarramendi JJ; Guerrero-Setas D
    Oncotarget; 2017 Feb; 8(9):15789-15801. PubMed ID: 28178655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.
    Zhang Y; Yang YL; Zhang FL; Liao XH; Shao ZM; Li DQ
    Cancer Med; 2018 Apr; 7(4):1317-1325. PubMed ID: 29473320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of early menarche with breast tumor molecular features and recurrence.
    Harris AR; Wang T; Heng YJ; Baker GM; Le PA; Wang J; Ambrosone C; Brufsky A; Couch FJ; Modugno F; Scott CG; Vachon CM; Hankinson SE; Rosner BA; Tamimi RM; Peng C; Eliassen AH
    Breast Cancer Res; 2024 Jun; 26(1):102. PubMed ID: 38886818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.
    Triki H; Declerck K; Charfi S; Ben Kridis W; Chaabane K; Ben Halima S; Sellami T; Rebai A; Berghe WV; Cherif B
    Cancer Immunol Immunother; 2022 May; 71(5):1139-1155. PubMed ID: 34608548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.
    Avraham A; Cho SS; Uhlmann R; Polak ML; Sandbank J; Karni T; Pappo I; Halperin R; Vaknin Z; Sella A; Sukumar S; Evron E
    PLoS One; 2014; 9(3):e91805. PubMed ID: 24651077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients.
    Lee NY; Hum M; Tan GP; Seah AC; Ong PY; Kin PT; Lim CW; Samol J; Tan NC; Law HY; Tan MH; Lee SC; Ang P; Lee ASG
    Clin Epigenetics; 2024 May; 16(1):66. PubMed ID: 38750495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: A potential therapeutic target.
    Liu S; Yin P; Xu J; Dotts AJ; Kujawa SA; Coon V JS; Zhao H; Dai Y; Bulun SE
    Stem Cell Reports; 2021 Sep; 16(9):2099-2106. PubMed ID: 34388365
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
    Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Patterns in Normal Tissue Correlate more Strongly with Breast Cancer Status than Copy-Number Variants.
    Gao Y; Widschwendter M; Teschendorff AE
    EBioMedicine; 2018 May; 31():243-252. PubMed ID: 29735413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation signatures of breast cancer in peripheral T-cells.
    Parashar S; Cheishvili D; Mahmood N; Arakelian A; Tanvir I; Khan HA; Kremer R; Mihalcioiu C; Szyf M; Rabbani SA
    BMC Cancer; 2018 May; 18(1):574. PubMed ID: 29776342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index, diet, and exercise: testing possible linkages to breast cancer risk via DNA methylation.
    Gillman AS; Gardiner CK; Koljack CE; Bryan AD
    Breast Cancer Res Treat; 2018 Feb; 168(1):241-248. PubMed ID: 29127590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Super-Enhancer Epigenetic Signature for Overall Survival Prediction in Patients with Breast Invasive Carcinoma.
    Yang X; Zheng W; Li M; Zhang S
    Bioinform Biol Insights; 2023; 17():11779322231162767. PubMed ID: 37020500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidences from a Systematic Review and Meta-Analysis Unveil the Role of MiRNA Polymorphisms in the Predisposition to Female Neoplasms.
    Bastami M; Choupani J; Saadatian Z; Zununi Vahed S; Ouladsahebmadarek E; Mansoori Y; Daraei A; Samadi Kafil H; Yousefi B; Mahdipour M; Masotti A; Nariman-Saleh-Fam Z
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31615040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
    J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A methylation signature at the CpG island promoter of estrogen receptor beta (ER-β) in breasts of women may be an early footmark of lack of breastfeeding and nulliparity.
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Roshan SJ; Bayani N; Tavakkoly-Bazzaz J
    Pathol Res Pract; 2021 Feb; 218():153328. PubMed ID: 33422777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.